Medical-Necessity Criteria Are a Contested Space. Here is How to Read Your Plan's.

Most people who deal with an insurance denial for addiction treatment hear a phrase that sounds objective and settled: "This service is not medically necessary based on our criteria." What that phrase obscures is that "medical necessity" is not a single, universally-agreed-upon standard. It is a contested technical space where payers, providers, and regulators disagree about what treatment is appropriate for whom, and the specific criteria one payer uses may differ substantially from another payer's criteria for the same clinical situation.

For more than a decade this contested space operated largely in the dark. Payers drafted medical-necessity criteria internally, shared them with treatment-center utilization-review teams on a need-to-know basis, and rarely published them. Patients who received denials had no real way to audit whether the criteria were reasonable — only whether the denial followed the criteria. The 2024 federal parity rule changed that, requiring payers to publish their criteria and disclose them to plan participants on request. This is an operational guide to reading, comparing, and leveraging those newly available criteria.

What "medical necessity" actually means in payer practice

In its most general sense, "medical necessity" is the clinical justification for a service. A service is medically necessary if it is: (1) consistent with accepted standards of care; (2) clinically appropriate for the patient's condition; (3) not more intensive than the situation requires; and (4) not primarily for the convenience of patient or provider. Every payer's definition includes some variation on these four prongs.

The contested space is not the general definition — it is how the four prongs are operationalized. How do you decide what "accepted standards of care" are? Which documents, which clinical bodies, which level of evidence? How do you decide "clinical appropriateness" when a patient presents a clinical picture that the criteria document did not anticipate? How do you weigh "not more intensive than required" against the real-world observation that less-intensive treatment often fails and escalates cost over time?

Different payers resolve these questions differently. Some rely heavily on internal criteria documents (proprietary, developed by the payer's medical staff). Some license external criteria products (MCG Health, InterQual — these are commercial utilization-review products used by payers and hospitals). Some align their criteria with consensus external standards like the ASAM Criteria. These choices are consequential. A payer whose criteria derive from MCG can produce a very different medical-necessity determination than a payer whose criteria derive from ASAM, for the same patient.

The 2020 Wit v. United Behavioral Health ruling

The contested nature of these criteria was exposed in federal court in March 2020. In Wit v. UBH, a federal judge ruled that the internal medical-necessity criteria UBH (then a subsidiary of UnitedHealthcare, now Optum) had been using for mental-health and substance-use determinations were not aligned with "generally accepted standards of care." The judge found that UBH's criteria systematically steered toward less-intensive treatment regardless of what the clinical situation warranted, and that the disparity was driven by cost considerations rather than clinical judgment.

The Wit ruling was a watershed. It established that internal medical-necessity criteria are reviewable in court against an objective standard — and that a payer whose criteria fail the review can be required to reprocess tens of thousands of historical denials. The decision accelerated a broader regulatory movement toward transparency and consensus-alignment in payer criteria, culminating in the 2024 federal parity rule.

What the 2024 parity rule requires

Under the 2024 Final Rule on the Mental Health Parity and Addiction Equity Act (MHPAEA), group health plans must: (1) conduct a written comparative analysis demonstrating that their non-quantitative treatment limits — including medical-necessity criteria — are applied no more stringently to mental-health and substance-use care than to medical-surgical care; (2) document the specific clinical frameworks their criteria draw from; (3) make these documents available to plan participants, regulators, and litigants on request, within ten business days.

Operationally, this means a patient facing a denial now has the right to request: "The specific medical-necessity criteria applied to my claim; the comparative analysis your plan produced demonstrating that these criteria are applied equivalently to medical-surgical services; and the clinical sources your plan uses to justify departures from published consensus standards such as the ASAM Criteria." A plan that refuses to produce these documents is committing a parity violation independent of the underlying denial.

How to read a medical-necessity criteria document

When you obtain a copy of the criteria used in your denial (in a format that may range from a plain-language summary to a technical framework document), read for three things:

1. What clinical source does the document cite? If the document references ASAM Criteria, SAMHSA TIPs, or DSM-5-TR, it is aligned with consensus external standards. If the document references MCG, InterQual, or an internal document without external citation, the criteria are proprietary — which does not make them wrong, but makes them more challengeable.

2. What specific thresholds do they apply? Criteria often specify thresholds like "must have demonstrated failure at a lower level of care within the past 12 months" or "must have documented risk of dangerous withdrawal." Compare the thresholds against your actual clinical picture. If the criteria require "prior outpatient failure" and you have not had a documented outpatient trial, that may seem to disqualify residential — but it is worth asking whether the requirement is itself clinically reasonable for your specific situation.

3. What appeal standards do they describe? Criteria documents often describe what additional documentation would change the determination. A thorough ASAM 4e assessment from an independent clinician is powerful. A peer-review call with the plan's medical director is often offered as an appeal step. Documented prior outpatient-trial failure is often dispositive.

Where criteria disputes go next

If a patient disagrees with a denial grounded in internal criteria, the escalation path is: internal appeal (first level) → internal appeal (second level, where available) → external review through an Independent Review Organization (IRO) or state insurance commissioner. For employer-sponsored plans governed by ERISA, federal court is the ultimate remedy. The 2024 parity rule has added a specific enforcement avenue through the Department of Labor for plans that fail to produce requested criteria documentation.

The practical tip: the most productive appeals cite specific criteria documents. Instead of arguing "my treatment should be covered," an effective appeal argues "the criteria your plan applied require X; my clinical documentation shows Y, which meets that threshold; therefore the denial is inconsistent with your own criteria." This kind of internal-to-the-criteria argument is harder for payers to dismiss than a general clinical disagreement.

What this shift means in 2026

The dynamic is shifting, slowly, from "payer decides unilaterally" toward "payer decides against an auditable standard." The shift is incomplete. Enforcement of the 2024 rule is uneven across states and administrative agencies. Plans sometimes delay disclosure of criteria. Treatment centers sometimes fail to advise patients of their rights to request documentation. But the direction of travel is clear: medical-necessity criteria, once a black box, are increasingly reviewable. A patient in 2026 has materially more leverage than a patient in 2022 had, and that leverage is worth using.

Sources

1. Wit v. United Behavioral Health. Case No. 14-cv-02346 (N.D. Cal., March 5, 2019; March 5, 2020 ruling).
2. DOL/HHS/Treasury. Mental Health Parity and Addiction Equity Act (MHPAEA) 2024 Final Rule.
3. ASAM. The ASAM Criteria, 4th edition — consensus external standard for addiction medical necessity.
4. SAMHSA. Treatment Improvement Protocols (TIPs) — clinical guidelines cited in most payer criteria.
5. MCG Health / InterQual. Commercial utilization-review criteria products, frequently referenced in payer internal criteria.